HEPION PHARMACEUTICALS, INC. Proceeds from Related Party Debt
HEPION PHARMACEUTICALS, INC. (HEPA) reported Proceeds from Related Party Debt of $350.00 thousand for the 8-month period ending 2013-12-31, per its 10-Q filed 2014-02-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2014-02-05
- HEPION PHARMACEUTICALS, INC. proceeds from related party debt for the quarter ending 2013-12-31 was $150.00K.
- HEPION PHARMACEUTICALS, INC. proceeds from related party debt for the quarter ending 2013-09-30 was $100.00K.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 5 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 8 month |
|---|---|---|---|---|
| 2013-12-31 | $150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | $250.00K 10-Q · filed 2014-02-05 | $350.00K 10-Q · filed 2014-02-05 | |
| 2013-09-30 | $100.00K 10-Q · filed 2013-11-19 | $200.00K 10-Q · filed 2013-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |